CCL5 and osteosarcoma: For example, in breast cancer, intratumoral MSCs express chemokine ligand 5 (CCL5) that promotes invasion and metastasis13, and co-inoculation with MSCs promotes progression and metastasis of both osteosarcoma and ovarian cancer42,43.